158 related articles for article (PubMed ID: 18565966)
1. Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven).
Viuff D; Lauritzen B; Pusateri AE; Andersen S; Rojkjaer R; Johansson PI
Br J Anaesth; 2008 Sep; 101(3):324-31. PubMed ID: 18565966
[TBL] [Abstract][Full Text] [Related]
2. Effect of hemodilution on coagulation and recombinant factor VIIa efficacy in human blood in vitro.
Darlington DN; Delgado AV; Kheirabadi BS; Fedyk CG; Scherer MR; Pusateri AE; Wade CE; Cap AP; Holcomb JB; Dubick MA
J Trauma; 2011 Nov; 71(5):1152-63. PubMed ID: 21610535
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VIIa and fibrinogen display additive effect during in vitro haemodilution with crystalloids.
Fenger-Eriksen C; Tønnesen E; Ingerslev J; Sørensen B
Acta Anaesthesiol Scand; 2009 Mar; 53(3):332-8. PubMed ID: 19243319
[TBL] [Abstract][Full Text] [Related]
4. rFVIIa and NN1731 reduce bleeding in hydroxyethyl starch hemodiluted rabbits.
Lauritzen B; Viuff D; Tranholm M; Ezban M
J Trauma; 2010 Nov; 69(5):1196-202. PubMed ID: 20032791
[TBL] [Abstract][Full Text] [Related]
5. In vitro effect of activated recombinant factor VII (rFVIIa) on coagulation properties of human blood at hypothermic temperatures.
Kheirabadi BS; Delgado AV; Dubick MA; Scherer MR; Fedyk CG; Holcomb JB; Pusateri AE
J Trauma; 2007 Nov; 63(5):1079-86. PubMed ID: 17993954
[TBL] [Abstract][Full Text] [Related]
6. Free oscillation rheometry monitoring of haemodilution and hypothermia and correction with fibrinogen and factor XIII concentrates.
Winstedt D; Tynngård N; Olanders K; Schött U
Scand J Trauma Resusc Emerg Med; 2013 Mar; 21():20. PubMed ID: 23517637
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT.
Konrad CJ; Markl TJ; Schuepfer GK; Schmeck J; Gerber HR
Anesth Analg; 2000 Feb; 90(2):274-9. PubMed ID: 10648306
[TBL] [Abstract][Full Text] [Related]
8. Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation.
Egli GA; Zollinger A; Seifert B; Popovic D; Pasch T; Spahn DR
Br J Anaesth; 1997 Jun; 78(6):684-9. PubMed ID: 9215020
[TBL] [Abstract][Full Text] [Related]
9. Effects on coagulation of balanced (130/0.42) and non-balanced (130/0.4) hydroxyethyl starch or gelatin compared with balanced Ringer's solution: an in vitro study using two different viscoelastic coagulation tests ROTEMTM and SONOCLOTTM.
Casutt M; Kristoffy A; Schuepfer G; Spahn DR; Konrad C
Br J Anaesth; 2010 Sep; 105(3):273-81. PubMed ID: 20659913
[TBL] [Abstract][Full Text] [Related]
10. Low dose of hydroxyethyl starch impairs clot formation as assessed by viscoelastic devices.
Tynngård N; Berlin G; Samuelsson A; Berg S
Scand J Clin Lab Invest; 2014 Jun; 74(4):344-50. PubMed ID: 24621204
[TBL] [Abstract][Full Text] [Related]
11. Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates.
Caballo C; Escolar G; Diaz-Ricart M; Lopez-Vílchez I; Lozano M; Cid J; Pino M; Beltrán J; Basora M; Pereira A; Galan AM
Blood Transfus; 2013 Jul; 11(3):391-9. PubMed ID: 23058866
[TBL] [Abstract][Full Text] [Related]
12. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation.
Ruttmann TG; James MF; Aronson I
Br J Anaesth; 1998 May; 80(5):612-6. PubMed ID: 9691864
[TBL] [Abstract][Full Text] [Related]
13. Coagulation effects of in vitro serial haemodilution with a balanced electrolyte hetastarch solution compared with a saline-based hetastarch solution and lactated Ringer's solution.
Roche AM; James MF; Grocott MP; Mythen MG
Anaesthesia; 2002 Oct; 57(10):950-5. PubMed ID: 12358952
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyethyl starch impairs in vitro coagulation.
Niemi TT; Kuitunen AH
Acta Anaesthesiol Scand; 1998 Oct; 42(9):1104-9. PubMed ID: 9809097
[TBL] [Abstract][Full Text] [Related]
15. The effects of haemodilution with hydroxyethyl starch 130/0.4 solution on coagulation as assessed by thromboelastography and platelet receptor function studies in vitro.
Williams P; Yang K; Kershaw G; Wong G; Dunkley S; Kam PC
Anaesth Intensive Care; 2015 Nov; 43(6):734-9. PubMed ID: 26603798
[TBL] [Abstract][Full Text] [Related]
16. Activity of recombinant factor VIIa under different conditions in vitro: effect of temperature, pH, and haemodilution.
Bladbjerg EM; Jespersen J
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):369-74. PubMed ID: 18600084
[TBL] [Abstract][Full Text] [Related]
17. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography.
Jamnicki M; Zollinger A; Seifert B; Popovic D; Pasch T; Spahn DR
Anesth Analg; 1998 Nov; 87(5):989-93. PubMed ID: 9806670
[TBL] [Abstract][Full Text] [Related]
18. [Effect of acute progressive normovolemic hemodilution with lactated Ringer's, gelatin and hydroxyethyl starch on coagulation and survival rate in rabbits].
Li LY; Xu X
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 40(3):292-300. PubMed ID: 18560458
[TBL] [Abstract][Full Text] [Related]
19. Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review.
Hartog CS; Reuter D; Loesche W; Hofmann M; Reinhart K
Intensive Care Med; 2011 Nov; 37(11):1725-37. PubMed ID: 21989733
[TBL] [Abstract][Full Text] [Related]
20. Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight.
Entholzner EK; Mielke LL; Calatzis AN; Feyh J; Hipp R; Hargasser SR
Acta Anaesthesiol Scand; 2000 Oct; 44(9):1116-21. PubMed ID: 11028733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
